JP2022516199A5 - - Google Patents

Info

Publication number
JP2022516199A5
JP2022516199A5 JP2021539453A JP2021539453A JP2022516199A5 JP 2022516199 A5 JP2022516199 A5 JP 2022516199A5 JP 2021539453 A JP2021539453 A JP 2021539453A JP 2021539453 A JP2021539453 A JP 2021539453A JP 2022516199 A5 JP2022516199 A5 JP 2022516199A5
Authority
JP
Japan
Application number
JP2021539453A
Other languages
Japanese (ja)
Other versions
JP7630173B2 (ja
JPWO2020143548A5 (https=
JP2022516199A (ja
Filing date
Publication date
Priority claimed from CN201911412811.1A external-priority patent/CN111407881A/zh
Application filed filed Critical
Publication of JP2022516199A publication Critical patent/JP2022516199A/ja
Publication of JPWO2020143548A5 publication Critical patent/JPWO2020143548A5/ja
Publication of JP2022516199A5 publication Critical patent/JP2022516199A5/ja
Priority to JP2024219524A priority Critical patent/JP7825894B2/ja
Application granted granted Critical
Publication of JP7630173B2 publication Critical patent/JP7630173B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021539453A 2019-01-07 2020-01-03 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物 Active JP7630173B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024219524A JP7825894B2 (ja) 2019-01-07 2024-12-16 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN201910015257.7 2019-01-07
CN201910015257 2019-01-07
CN201911412811.1 2019-12-31
CN201911412811.1A CN111407881A (zh) 2019-01-07 2019-12-31 神经调节蛋白用于预防、治疗或延迟心肌损伤的方法和组合物
PCT/CN2020/070299 WO2020143548A1 (zh) 2019-01-07 2020-01-03 神经调节蛋白用于预防、治疗或延迟心肌损伤的方法和组合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024219524A Division JP7825894B2 (ja) 2019-01-07 2024-12-16 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物

Publications (4)

Publication Number Publication Date
JP2022516199A JP2022516199A (ja) 2022-02-24
JPWO2020143548A5 JPWO2020143548A5 (https=) 2022-12-19
JP2022516199A5 true JP2022516199A5 (https=) 2022-12-19
JP7630173B2 JP7630173B2 (ja) 2025-02-17

Family

ID=71485079

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021539453A Active JP7630173B2 (ja) 2019-01-07 2020-01-03 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物
JP2024219524A Active JP7825894B2 (ja) 2019-01-07 2024-12-16 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024219524A Active JP7825894B2 (ja) 2019-01-07 2024-12-16 ニューレグリンを用いて心筋損傷を予防、治療、又は緩和するための方法及びそのための組成物

Country Status (7)

Country Link
US (1) US20220096599A1 (https=)
EP (1) EP3909599A4 (https=)
JP (2) JP7630173B2 (https=)
CN (1) CN111407881A (https=)
AU (1) AU2020206381B2 (https=)
CA (1) CA3125377A1 (https=)
WO (1) WO2020143548A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118236430B (zh) * 2024-04-07 2025-08-26 中国人民解放军总医院第六医学中心 一种修复肿瘤治疗心肌损伤的药物组合物及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5716930A (en) 1991-04-10 1998-02-10 Ludwig Institute For Cancer Research Glial growth factors
US5530109A (en) 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5912326A (en) 1995-09-08 1999-06-15 President And Fellows Of Harvard College Cerebellum-derived growth factors
US6635249B1 (en) 1999-04-23 2003-10-21 Cenes Pharmaceuticals, Inc. Methods for treating congestive heart failure
US20010041869A1 (en) 2000-03-23 2001-11-15 Causey James D. Control tabs for infusion devices and methods of using the same
US6589229B1 (en) 2000-07-31 2003-07-08 Becton, Dickinson And Company Wearable, self-contained drug infusion device
CN1498656A (zh) * 2002-11-08 2004-05-26 上海泽生科技开发有限公司 神经调节蛋白用于心肌梗死治疗的方法和组合物
WO2003099320A1 (en) * 2002-05-24 2003-12-04 Zensun (Shanghai) Sci-Tech.Ltd Neuregulin based methods and compositions for treating viral myocarditis and dilated cardiomyopathy
US7144384B2 (en) 2002-09-30 2006-12-05 Insulet Corporation Dispenser components and methods for patient infusion device
US7128727B2 (en) 2002-09-30 2006-10-31 Flaherty J Christopher Components and methods for patient infusion device
US20050065760A1 (en) 2003-09-23 2005-03-24 Robert Murtfeldt Method for advising patients concerning doses of insulin
US7686787B2 (en) 2005-05-06 2010-03-30 Medtronic Minimed, Inc. Infusion device and method with disposable portion
JP5738516B2 (ja) * 2005-12-30 2015-06-24 ゼンサン (シャンハイ) サイエンス アンド テクノロジー リミテッド 心機能改善のためのニューレグリンの徐放
CN101394861A (zh) * 2005-12-30 2009-03-25 上海泽生科技开发有限公司 纽兰格林持续给药能改善心脏功能
CN103768582A (zh) * 2006-12-29 2014-05-07 上海泽生科技开发有限公司 纽兰格林持续给药能改善心脏功能
CN102245189B (zh) * 2008-12-03 2015-06-17 阿莫塞特公司 改善梗死区灌注的组合物以及血管损伤修复方法
CN102470161A (zh) * 2009-06-09 2012-05-23 上海泽生科技开发有限公司 神经调节蛋白用于治疗心力衰竭的有效剂量
JP6096262B2 (ja) * 2009-08-25 2017-03-15 ゼンサン (シャンハイ) サイエンス アンド テクノロジー,シーオー.,エルティーディー. ニューレグリンに基づく心不全の治療方法
CN102139095A (zh) * 2010-01-29 2011-08-03 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟心脏缺血再灌注损伤的方法和组合物
WO2013053076A1 (en) * 2011-10-10 2013-04-18 Zensun (Shanghai)Science & Technology Limited Compositions and methods for treating heart failure
CN103127579B (zh) 2011-11-21 2017-06-16 上海泽生科技开发股份有限公司 便携式注射泵的驱动系统
US10894815B2 (en) * 2012-10-08 2021-01-19 Zensun (Shanghai) Science & Technology, Co., Ltd. Compositions and methods for treating heart failure in diabetic patients
EP2964249A1 (en) * 2013-03-06 2016-01-13 Acorda Therapeutics, Inc. Therapeutic dosing of a neuregulin or a fragment thereof for treatment or prophylaxis of heart failure
RU2015154737A (ru) * 2013-05-22 2017-06-27 Цзэньсунь (Шанхай) Сайенс Энд Текнолоджи, Ко., Лтд. Пролонгированное высвобождение нейрегулина для лечения сердечной недостаточности
CN105561298A (zh) * 2014-10-17 2016-05-11 上海泽生科技开发有限公司 神经调节蛋白用于预防、治疗或延迟射血分数保留的心力衰竭的方法和组合物
CN108474787A (zh) * 2015-09-25 2018-08-31 道格拉斯.B.索耶 用于治疗心脏损伤的方法
WO2018052374A1 (en) * 2016-09-14 2018-03-22 Agency For Science, Technology And Research Modulation of tjp1 expression to regulate regeneration of heart cells
JP2017125032A (ja) * 2017-02-20 2017-07-20 ゼンスン(シャンハイ)サイエンス アンド テクノロジー カンパニー リミテッド 糖尿病患者における心不全の治療用組成物

Similar Documents

Publication Publication Date Title
JP2022516199A5 (https=)
CN305531460S (https=)
CN305793539S (https=)
CN305739827S (https=)
CN305738461S (https=)
CN305736678S (https=)
CN305722308S (https=)
CN305746546S (https=)
CN305533812S (https=)
CN305533514S (https=)
CN305533462S (https=)
CN305533434S (https=)
CN305532989S (https=)
CN305532356S (https=)
CN305532189S (https=)
CN305531416S (https=)
CN305748617S (https=)
CN305531362S (https=)
CN305530026S (https=)
CN305529065S (https=)
CN305528205S (https=)
CN305527900S (https=)
CN305692129S (https=)
CN305527238S (https=)
CN305693707S (https=)